Virginia Arechavala‐Gomeza

Author

Also Known As

Arechavala-Gomeza V, F. Gonzalez, Francesco Muntoni, V. Arechavala-Gomeza, V. Arechavala‐Gomeza, Virginia Arechavala-Gomeza, Virginia Arechavala‐Gomeza

Publications

Citations

H-Index

Concepts

All Affiliations

University College London Newcastle University Royal Holloway University of London Leiden University Medical Center BioCruces Health research Institute

About

Virginia Arechavala‐Gomeza is an author at University College London specializing in medicine, urology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.2K
2	Health Sciences	3	3	172
3	Biostatistics	2	2	193
4	Engineering	1	1	45
5	Natural Sciences	1	1	149

Virginia Arechavala‐Gomeza

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study Sebahattin Çirak, Virginia Arechavala‐Gomeza, Michela Guglieri, The Lancet Exon SkippingUrologyDuchenne Muscular DystrophyPhase 2Medicine	2011	852
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study Maria Kinali, Virginia Arechavala‐Gomeza, Lucy Feng, The Lancet Neurology	2009	635
Muscle histology vs MRI in Duchenne muscular dystrophy Maria Kinali, Virginia Arechavala‐Gomeza, Sebahattin Çirak, Neurology	2011	152
Comparative Analysis of Antisense Oligonucleotide Sequences for Targeted Skipping of Exon 51 During Dystrophin Pre-mRNA Splicing in Human Muscle Virginia Arechavala‐Gomeza, Ian R. Graham, Linda Popplewell, Human Gene Therapy Exon SkippingAntisense Oligonucleotide SequencesDuchenne Muscular DystrophyNatural SciencesMolecular Biology	2007	149
Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials Karen Anthony, Sebahattin Çirak, Silvia Torelli, Brain GeneticsBecker Muscular DystrophyDystrophin QuantificationMolecular BiologyMolecular Genetics	2011	148
A Duchenne Muscular Dystrophy Gene Hot Spot Mutation in Dystrophin-Deficient Cavalier King Charles Spaniels Is Amenable to Exon 51 Skipping Gemma Walmsley, Virginia Arechavala‐Gomeza, Marta Fernández-Fuente, PLoS ONE	2010	126
Biochemical Characterization of Patients With In-Frame or Out-of-Frame<i>DMD</i>Deletions Pertinent to Exon 44 or 45 Skipping Karen Anthony, Virginia Arechavala‐Gomeza, Valeria Ricotti, JAMA Neurology	2013	106
Restoration of the Dystrophin-associated Glycoprotein Complex After Exon Skipping Therapy in Duchenne Muscular Dystrophy Sebahattin Çirak, Lucy Feng, Karen Anthony, Molecular Therapy	2011	102
Chronic Systemic Therapy With Low-dose Morpholino Oligomers Ameliorates the Pathology and Normalizes Locomotor Behavior in mdx Mice Alberto Malerba, Paul Sharp, Ian R. Graham, Molecular Therapy	2010	94
Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: Implication for clinical trials Virginia Arechavala‐Gomeza, Maria Kinali, Lucy Feng, Neuromuscular Disorders KinesiologySkeletal MuscleDuchenne Muscular DystrophyClinical TrialsDegenerative Disease	2010	90

Page 1